Versant Venture Management, LLC Portfolio Holdings
Versant Venture Management, LLC
- $61.3 Million
- Q3 2025
Versant Venture Management, LLC has filed its 13F form on November 10, 2025 for Q3 2025 where it was disclosed a total value porftolio of $61.3 Million distributed in 9 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Monte Rosa Therapeutics, Inc. with a value of $41.9M, Crispr Therapeutics Ag with a value of $9.65M, Repare Therapeutics Inc. with a value of $4.66M, Tempest Therapeutics, Inc. with a value of $2.77M, and Adverum Biotechnologies, Inc. with a value of $2.33M.
Examining the 13F form we can see an increase of $4.95M in the current position value, from $56.3M to 61.3M.
Versant Venture Management, LLC is based out at San Francisco, CA
Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.